Free beta access. 5 free AI tokens each week. Optional top-ups available. See what is included
Opening Word document…

Multinational Medical Coordination Centre / European Medical Command (MMCC/EMC ) capacity is key to surge against future pandemics, but vaccine response needs to move from just-in-time focus to long term planning

Rico Maderthoner, 11-21-2021, Commander J.G. (OF-3) Germany Navy, https://military-medicine.com/article/4175-m3-eps-a-surge-capacity-concept-for-pandemics-crises.html, "M3-EPS: A Surge Capacity Concept for Pandemics and Crises," No Publication (ermo/sms, Acc:6-20-2022)

In late 2019, severe acute respiratory syndrome coronavirus 2 was first identified and has since led to the ongoing global COVID-19 pandemic. This pandemic has highlighted the lack of rapidly deployable reinforcement elements and systems as well as the benefits of stockpiles of medical equipment. A differentiation must be made between non-expendable medical supplies (i.e. medical devices1) and individually issued expendable medical supplies. The need for both expendable and non-expendable medical supplies could not be sufficiently satisfied in all areas as manufacturing nowadays is based on just-in-time practices without contingency stockpiling.

Production losses and market contractions as well as the concentration of production facilities in countries outside of Europe have in recent years frequently led to supply shortages across Europe for various drugs (including antibiotics, cytostatic agents, and vaccines). What is more, the pressure to reduce costs has in recent years led to a considerable reduction in civilian and military stockpiles of medical materials, including non-expendable medical supplies, in favour of just-in-time production.

The COVID-19 pandemic has led to an increased awareness among policymakers and the general public of pandemic and epidemic threat scenarios and their consequences.

In response to the rapid spread of COVID-19, the World Health Organization (WHO) and the Robert Koch Institute (RKI) made recommendations for improving preparations for further possible waves of COVID-19. In addition, the European Commission announced the creation of the rescEU strategic stockpile of medical equipment. (2)

The mission of the Multinational Medical Coordination Centre / European Medical Command is to support the medical services of NATO and the EU by coordinating medical capability development. One of the lessons learned in the management of major incidents, the Ebola crisis, and the current pandemic is that public health is becoming increasingly important for external and internal security.

As part of its programme of work, the MMCC/EMC was tasked in the spring of 2020 with improving cooperation between medical services and with enhancing their responsiveness so that they are better prepared for possible further COVID-19 waves, which may occur in combination with a seasonal flu epidemic.

In April 2020, the MMCC/EMC was asked by the Euro-Atlantic Disaster Response Coordination Centre (EADRCC) of NATO Headquarters in Brussels to quickly develop a concept for military medical stockpiling. This is the basis for the NATO Pandemic Response Trust Fund. Many nations have contributed financial resources and material to the trust fund on the basis of this concept. The NATO Support and Procurement Agency (NSPA) is responsible for managing the purchase and storage of trust fund items. The NATO Euro-Atlantic Disaster Response Coordination Centre helps coordinate requests for assistance from countries. In October and November 2020, the NATO member states Albania, Montenegro and North Macedonia received ventilators and medical supplies with a total value of €1.5 million.

The purpose of the M3-EPS concept developed by the MMCC/EMC is to maintain limited stockpiles to ensure surge capacity in the event of a critical development such as the COVID-19 pandemic.

The objective is to learn from the current COVID-19 pandemic so that medical services are more effectively and efficiently prepared for future epidemics and pandemics and are able to respond quickly. Rapidly deployable and modular standard packages with expendable and non-expendable medical materials are to be identified and defined for stockpiling. At the same time, the stockpiling efforts of the medical services must be supported.

Three Phases of Development

The concept was developed in three phases:

• Phase 1: The response capability of medical forces of the multinational EU Battlegroup 2020-2 (EU-BG-2020-2) will be improved for deployment with a modular initial COVID-19 capability (focusing on self-protection) to manage the COVID-19 pandemic or a local COVID-19 outbreak.

• Phase 2: The various modular, rapidly deployable standard packages will be harmonised with the nations participating in the MMCC/EMC and – wherever possible – will be aligned with comparable stockpiling preparations of the military and civilian bodies of NATO and the EU.

• Phase 3: A multinational concept will be developed which can be used not only for deployments to manage COVID-19 but also for other infectious diseases (those caused by other pathogens).

The modular standard packages can be used to support military medical facilities in international missions, to help hospitals in Germany and the EU, and to provide assistance, including administrative support, in theatres of operation. The concept includes a calculator that is used to compute costs, storage space, and personnel requirements for each module. The calculator uses defined parameters to generate a list of generic names for essential expendable and non-expendable medical material. This list helps users determine and procure what is actually needed.

Sign in to recut, update, or save this card.